🎁 Black Friday: up to 50% off of annual plans
Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.390
-0.060 (-4.14%)
At close: Nov 20, 2026, 4:00 PM EST
1.319
-0.071 (-5.12%)
After-hours: Nov 20, 2026, 6:22 PM EST

Artelo Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.32-12.88-9.83-9.29-10.08-12.11
Depreciation & Amortization
0.5-----
Other Amortization
0.180.21----
Loss (Gain) From Sale of Investments
---0.28-0.64-0.21-0.02
Stock-Based Compensation
0.991.140.821.022.462.8
Other Operating Activities
1.441.260.030.040.040.03
Change in Accounts Payable
-3.51.590.480.270.021.5
Change in Other Net Operating Assets
-0.040.160.430.39-0.24-0.21
Operating Cash Flow
-11.76-8.52-8.35-8.21-8.01-8
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
--7.773.512.96-30.1
Other Investing Activities
0.19-0.06----
Investing Cash Flow
0.19-0.067.773.512.96-30.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.61----
Total Debt Issued
0.460.61----
Short-Term Debt Repaid
--0.02----
Total Debt Repaid
-1.27-0.02----0
Net Debt Issued (Repaid)
-0.80.58----0
Issuance of Common Stock
15.076.280.110.57-54.79
Financing Cash Flow
14.266.870.110.57-54.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.03-0.02-0.010.06-0.22-0.08
Net Cash Flow
2.72-1.74-0.48-4.07-5.2716.6

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.76-8.52-8.35-8.21-8.01-8
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.05-223.56-419.83-449.16-457.91-581.26
Levered Free Cash Flow
-8.03-4.17-4.7-4.64-4.31-
Unlevered Free Cash Flow
-8.06-4.2-4.7-4.64-4.3-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-3.541.750.910.66-0.221.29
SEC Filings: 10-K · 10-Q